NFE2L2 and multiple sclerosis: Dimethyl fumarate, a potent NRF2 enhancer in treating multiple sclerosis, demonstrates neuroprotection against MPTP- and α-synuclein-induced neurotoxicity in mice through activating NRF2 [75,76].